Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.
| Current Price | ₹21.05 |
|---|---|
| Market Cap | ₹6 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 6.5 |
| Return on Equity | 24.43% |
| 52-Week Range | ₹16.15 – ₹24.37 |
| Beta (1Y) | 0.49 |
| Dividend Yield | 0.00% |
Brawn Biotech Ltd. is trading at ₹21.05, with a market capitalisation of ₹6 Cr.
Brawn Biotech Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Brawn Biotech Ltd. has a P/E of 6.5 and a return on equity of 24.43%.